Godavari Biorefineries Limited

This was the first human trial of a new oral medication called MSP008-22, designed to fight advanced cancers. The study tested single, increasing doses in 7 patients with late-stage solid tumors to check if the drug was safe and how the body processed it. The goal was to gather i…

This was the first study in people to test the safety of a new oral drug called MSP008-22, which is being developed to treat COVID-19. It involved 64 healthy adult volunteers who received either the drug or a placebo (a dummy pill) to check for side effects and see how the drug m…